Stockscreener 앱 받기
0.7431
0.61%
0.0045
전일 마감가:
$0.7386
열려 있는:
$0.755
하루 거래량:
811.27K
Relative Volume:
0.27
시가총액:
$66.86M
수익:
-
순이익/손실:
$4.82M
주가수익비율:
10.96
EPS:
0.0678
순현금흐름:
$-140.90M
1주 성능:
+3.63%
1개월 성능:
+8.42%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.7306
$0.79
1주일 범위
$0.666
$0.79
52주 변동 폭
$0.50
$3.6999
Cypherpunk Technologies Inc Stock (CYPH) Company Profile
명칭
Cypherpunk Technologies Inc
전화
617 252 4343
주소
47 THORNDIKE STREET, CAMBRIDGE
Compare CYPH vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYPH
Cypherpunk Technologies Inc
|
0.7431 | 66.86M | 0 | 4.82M | -140.90M | 0.0678 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2021-10-04 | 개시 | Mizuho | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2020-06-29 | 개시 | Piper Sandler | Overweight |
| 2020-02-11 | 개시 | Robert W. Baird | Outperform |
| 2019-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | 재개 | Raymond James | Outperform |
| 2017-03-07 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Cypherpunk Technologies Inc 주식(CYPH)의 최신 뉴스
Cypherpunk Technologies restructures CoinXit equity compensation agreement - MSN
CYPH.O Technical Analysis & Stock Price Forecast - Intellectia AI
Top Cypherpunk Technologies (CYPH) Competitors 2026 - MarketBeat
Cypherpunk Technologies (CYPH) Stock Forecast and Price Target 2026 - MarketBeat
Cypherpunk Technologies Inc. - AD HOC NEWS
Cypherpunk Technologies (CYPH) director converts 104,500 RSUs to 152,500 share stake - Stock Titan
Cypherpunk (CYPH) director converts 168,750 vested RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) receives 168,750 shares from RSUs - Stock Titan
Director William Li of Cypherpunk (CYPH) receives 168,750 shares from RSU settlements - Stock Titan
RSU settlements give Cypherpunk (CYPH) director 168,750 common shares - Stock Titan
Cypherpunk Technologies (CYPH) director converts 168,750 RSUs into common shares - Stock Titan
Cypherpunk (CYPH) director converts 168,750 RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) gains 168,750 shares via RSU settlements - Stock Titan
Director Loscalzo acquires 168,750 Cypherpunk (CYPH) shares via RSUs - Stock Titan
Director Cavanaugh acquires 168,750 Cypherpunk (CYPH) shares from RSUs - Stock Titan
ZEC Rallies 20% After Cypherpunk Reports First Annual Profit - thedefiant.io
CYPH.O PE Ratio & Valuation, Is CYPH.O Overvalued - Intellectia AI
CYPH.O Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CYPH.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CYPH Should I Buy - Intellectia AI
CYPH.O Forecast — Price Prediction for 2026. Should I Buy CYPH.O? - Intellectia AI
Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart
Security Notice: Cysic Foundation X Account Breached - Bitget
Cypherpunk reports full year 2025 financial results - marketscreener.com
Cypherpunk Reports Full Year 2025 Financial Results - National Today
Cypherpunk Technologies Reports Transformational 2025 Financial Results - Intellectia AI
Cypherpunk Technologies 10-K: Revenue $0, EPS $0.07 on $4.8M Net Income - TradingView
CYPH: 2025 saw a strategic pivot to Zcash, a return to profitability, and major digital asset gains - TradingView
Cypherpunk Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cypherpunk Technologies (CYPH) pivots to Zcash while advancing cancer drugs - Stock Titan
CYPH: Returned to profitability in 2025 with strong ZEC gains, new capital, and clinical progress - TradingView
[8-K] CYPHERPUNK TECHNOLOGIES INC. Reports Material Event | CYPH SEC FilingForm 8-K - Stock Titan
Cypherpunk Technologies Inc. (CYPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cypherpunk Technologies Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
Cypherpunk Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Cypherpunk (CYPH) after shares stay below $1 minimum bid - Stock Titan
Zcash Open Development Lab announced that it has received $25 million in funding from a group of investors - marketscreener.com
Cypherpunk Technologies: $5 Million Investment In Zcash Open Development Lab To Advance Privacy Infrastructure - Pulse 2.0
Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL) - Yellow.com
Cypherpunk Invests $5M in Zcash Company ZODL - Intellectia AI
Cypherpunk Makes $5M Investment into Zcash Open Development Lab - citybiz
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Leap Therapeutics, Inc. Common Stock (CYPH) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
CYPH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CYPH Technical Analysis & Stock Price Forecast - Intellectia AI
CYPH | Cypherpunk Technologies Inc. Common Institutional Ownership - Quiver Quantitative
Zcash Drops 60% as Treasury Buyer Hits Pause - Cointribune
Zcash Slides 60% as Treasury Buying Pauses and Cypherpunk’s Losses Mount - Bitget
Is crypto still cypherpunk? With Miden co-founder Azeem Khan - Yahoo Finance
Zcash Down Over 50% Since Winklevoss-Backed DAT’s Last Purchase - thedefiant.io
Billionaire twins–backed stock surges 100% after buying $50M ‘encrypted Bitcoin’ - MSN
Cypherpunk Technologies Inc (CYPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):